ACE and liver dysplastic nodule: Current standard treatment of DN targets the renin–angiotensin system (RAS) through usage of angiotensin converting enzyme (ACE) inhibitors to limit systemic blood pressure to control intraglomerular pressure (Bonegio and Susztak, 2012).